Citation Impact
Citing Papers
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21
2008
Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis
2016
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Breast cancer
2019 Standout
Algae as nutritional and functional food sources: revisiting our understanding
2016 Standout
Microalgae in modern cancer therapy: Current knowledge
2018 Standout
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
2015
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
2016
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
2010 Standout
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer
2005
Immune Checkpoint Blockade for Breast Cancer
2018
Breast cancer
2016 Standout
Image analysis and machine learning in digital pathology: Challenges and opportunities
2016 Standout
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
2022
Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007
2008
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
1997
Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte–associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer
2015
Marine microorganisms as a promising and sustainable source of bioactive molecules
2016
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Natural and therapy-induced immunosurveillance in breast cancer
2015
Nasopharyngeal carcinoma
2019 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
2015
Experimental vaccine strategies for cancer immunotherapy
1998
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Validation of a Nomogram to Predict the Risk of Nonsentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node Biopsy: Validation of the MSKCC Breast Nomogram
2009
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
2016
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
2017
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer
2017
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
2014
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Targeting autophagy in cancer
2017 Standout
Applications of machine learning in drug discovery and development
2019 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017
AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
2016
Targeting immune cells for cancer therapy
2019
BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer
2017
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
2016
MUC1‐derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue
2003 StandoutNobel
Lung Cancer in the Elderly
2007
Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study
2009
Breast Cancer Statistics, 2022
2022 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Prognostic significance of tumor‐infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large‐scale cohort study
2018
Immune targeting in breast cancer.
2015
Replication of ONYX-015, a Potential Anticancer Adenovirus, Is Independent of p53 Status in Tumor Cells
1998 StandoutNobel
Bioactivity Screening of Microalgae for Antioxidant, Anti-Inflammatory, Anticancer, Anti-Diabetes, and Antibacterial Activities
2016
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Fatty acids profile and temperature in the cultured marine diatom Odontella aurita
2014
Combination therapy in combating cancer
2017 Standout
Marine Microalgae with Anti-Cancer Properties
2018 Standout
Disseminated intravascular coagulation. Findings in 346 patients.
1980 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32
2010
The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ
2016
Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
2014
Biologically Active Metabolites Synthesized by Microalgae
2015
Works of Marie Mathieu being referenced
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer
2012
The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
2012
Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
2015
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study
2014
Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis
2003
Quality of life after sentinel lymph node biopsy in early breast cancer
2004
Strategies for cancer gene therapy using adenoviral vectors
1996
Individual benefits from adjuvant anthracycline-based chemotherapy can be predicted from a predictive nomogram created from primary chemotherapy (PC) data: Results of a randomized trial
2005